Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$17.75 - $41.6 $2.6 Million - $6.08 Million
146,252 Added 19.13%
910,599 $36.1 Million
Q4 2023

Feb 13, 2024

BUY
$8.54 - $20.22 $1.16 Million - $2.74 Million
135,422 Added 21.53%
764,347 $14.6 Million
Q3 2023

Nov 13, 2023

BUY
$10.13 - $13.98 $110,933 - $153,094
10,951 Added 1.77%
628,925 $7.2 Million
Q2 2023

Aug 11, 2023

BUY
$6.84 - $11.91 $422,486 - $735,644
61,767 Added 11.11%
617,974 $6.35 Million
Q1 2023

May 15, 2023

BUY
$7.0 - $8.75 $493,199 - $616,498
70,457 Added 14.5%
556,207 $4.29 Million
Q4 2022

Feb 13, 2023

BUY
$5.45 - $7.35 $1.28 Million - $1.72 Million
234,246 Added 93.14%
485,750 $3.57 Million
Q3 2022

Nov 14, 2022

BUY
$6.89 - $9.39 $24,197 - $32,977
3,512 Added 1.42%
251,504 $1.81 Million
Q2 2022

Aug 12, 2022

BUY
$6.71 - $9.52 $220,329 - $312,598
32,836 Added 15.26%
247,992 $2.11 Million
Q1 2022

May 13, 2022

BUY
$6.41 - $13.89 $118,520 - $256,826
18,490 Added 9.4%
215,156 $1.93 Million
Q4 2021

Feb 11, 2022

BUY
$10.41 - $13.95 $27,534 - $36,897
2,645 Added 1.36%
196,666 $2.72 Million
Q3 2021

Nov 12, 2021

BUY
$8.19 - $11.31 $20,335 - $28,082
2,483 Added 1.3%
194,021 $2.07 Million
Q2 2021

Aug 13, 2021

BUY
$8.81 - $15.03 $875,678 - $1.49 Million
99,396 Added 107.87%
191,538 $1.72 Million
Q1 2021

May 12, 2021

BUY
$10.02 - $13.92 $149,448 - $207,616
14,915 Added 19.31%
92,142 $976,000
Q4 2020

Feb 12, 2021

BUY
$7.42 - $15.96 $223,675 - $481,114
30,145 Added 64.03%
77,227 $973,000
Q3 2020

Nov 13, 2020

BUY
$7.15 - $11.5 $59,402 - $95,542
8,308 Added 21.43%
47,082 $413,000
Q2 2020

Aug 13, 2020

BUY
$2.77 - $12.1 $3,706 - $16,189
1,338 Added 3.57%
38,774 $376,000
Q1 2019

May 14, 2019

BUY
$4.09 - $7.19 $392 - $690
96 Added 0.26%
37,436 $256,000
Q3 2018

Nov 13, 2018

BUY
$5.68 - $8.59 $33,228 - $50,251
5,850 Added 18.58%
37,340 $236,000
Q3 2017

Nov 14, 2017

BUY
$8.0 - $11.6 $251,920 - $365,284
31,490
31,490 $364,000

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.